Kushim Tablets — Class II drug recall D-0840-2020
Terminated recall by B AND A TRADING CORPORATION, reported 2020-02-19, distributed in NJ, NY. Marketed Without an Approved NDA/ANDA. FDA analysis found product to contain cinobufagin, bufalin, and bufoten
| Recall number | D-0840-2020 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | B AND A TRADING CORPORATION, Carlstadt, NJ, United States |
| Recall initiated | 2020-01-28 |
| Classified | 2020-02-12 |
| Reported by FDA | 2020-02-19 |
| Terminated | 2023-12-21 |
| Distributed | NJ, NY |
| Quantity | 40 packages |
| Reason classes | unapproved product |
| Lot numbers | H003 |
Product
Kushim Tablets (Gushim) 45-count packages, Label in foreign language
Reason for recall
Marketed Without an Approved NDA/ANDA. FDA analysis found product to contain cinobufagin, bufalin, and bufotenine
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0840-2020. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.